T. Rowe Price Associates
XTNT icon

T. Rowe Price Associates’s Xtant Medical Holdings XTNT Stock Holding History

T. Rowe Price Associates’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,472
Closed -$25K – 2990
2021
Q2 		$25K Sell
15,472
-12,428
-45% -$22.1K ﹤0.01% 2911
2021
Q1 		$66K Buy
+27,900
New +$59.6K ﹤0.01% 2809

Other funds holding XTNT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates's XTNT Position: Q3 2021 in Review

T. Rowe Price Associates sold out of Xtant Medical Holdings (XTNT) in Q3 2021, closing a stake of 15,472 shares — an estimated $25K sold.

T. Rowe Price Associates first reported a position in XTNT in Q1 2021 and held it in 2 quarters. The position peaked at $66K in Q1 2021. 17 funds tracked by Wall St. Rank hold XTNT as of Q3 2021.

  • T. Rowe Price Associates reported no remaining Xtant Medical Holdings position as of Q3 2021 after selling out during the quarter.
  • T. Rowe Price Associates sold 15,472 Xtant Medical Holdings shares in Q3 2021, an estimated $25K.
  • T. Rowe Price Associates first reported a position in Xtant Medical Holdings in Q1 2021 and held it in 2 quarters.
  • T. Rowe Price Associates's Xtant Medical Holdings position peaked at $66K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q3 2021.

Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.